NCT05499793

Brief Summary

This study aimed to examine the impact of one gram of Zingiber Officinale powder on menopausal symptoms since a large number of menopausal women in this region (Duhok city in the North of Iraq) are reluctant to take the conventional treatment for improving their menopausal symptoms and they prefer of taking the ginger powder and surprisingly many of those patients reported positive effects on their symptoms and general well being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2022

Completed
Last Updated

August 12, 2022

Status Verified

August 1, 2022

Enrollment Period

3 months

First QC Date

August 7, 2022

Last Update Submit

August 11, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Impact of Zingiber Officinale on hot flush in menopausal women

    A significant change in the intensity of hot flushes was observed in the menopausal rating scale in menopausal women treated with ginger powder compared to pre-treatment.

    six weeks treatment with Zingiber Officinale powder

  • Impact of Zingiber Officinale on Night sweating in menopausal women

    A significant change in the intensity of night sweating was observed in the menopausal rating scale in menopausal women treated with ginger powder compared to pre-treatment.

    six weeks treatment with Zingiber Officinale powder

  • Impact of Zingiber Officinale on estrogen levels in menopausal women

    A significant change was observed in serum estrogen levels in menopausal women treated with ginger powder compared to pre-treatment.

    six weeks treatment with Zingiber Officinale powder

  • Impact of Zingiber Officinale on body weight in menopausal symptoms

    A significant change was observed in body weight in kilograms in menopausal women treated with ginger powder compared to pre-treatment.

    six weeks treatment with Zingiber Officinale powder

Study Arms (2)

Treatment group (Ginger)

EXPERIMENTAL

All the participants were given Zingiber Officinale powder (500 mg) capsules twice daily for twelve weeks. Zingiber Officinale capsules were purchased from Pure Mountain Botanicals, 1712 Pioneer Ave # 1139 Cheyenne Wyoming 82001 (USA)

Dietary Supplement: Zingiber Officinale powder

Control group (Placebo)

PLACEBO COMPARATOR

All the participants were given starch powder (50 mg) capsules twice daily for twelve weeks.

Dietary Supplement: Placebo

Interventions

Zingiber Officinale powderDIETARY_SUPPLEMENT

Ginger powder

Also known as: Ginger
Treatment group (Ginger)
PlaceboDIETARY_SUPPLEMENT

Starch powder

Also known as: control
Control group (Placebo)

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women living in Duhok city with self-reported menopause symptoms
  • Aged between 45 and 60 years

You may not qualify if:

  • Not on treatment for menopausal symptoms
  • Patients Having chronic diseases like hypertension, Ischemic heart diseases or Diabetes mellitus
  • Patients having coagulopathies
  • Patient's having hormone-dependent malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Duhok College of Pharmacy

Duhok, Kurdistan Region, 42001, Iraq

Location

MeSH Terms

Interventions

ginger extract

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
A pharmacist professional was responsible for distributing the treatment (ginger) and placebo and he was in charge to assign the participants to the groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc Student in clinical Pharmacology

Study Record Dates

First Submitted

August 7, 2022

First Posted

August 12, 2022

Study Start

December 1, 2021

Primary Completion

March 1, 2022

Study Completion

June 1, 2022

Last Updated

August 12, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

The collected Data will not be shared until the study has been published

Locations